2020
DOI: 10.1007/s00018-020-03645-1
|View full text |Cite
|
Sign up to set email alerts
|

Gut microbiota-derived tryptophan metabolism mediates renal fibrosis by aryl hydrocarbon receptor signaling activation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
97
1
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 125 publications
(102 citation statements)
references
References 104 publications
3
97
1
1
Order By: Relevance
“…Moreover, the metabolites of tryptophan metabolism can act as the ligands binding to specific receptors to elicited various pathologic cellular process. For example, kynurenine, serotonin and indole derivatives may bind to aryl hydrocarbon receptor (AHR), a cytoplasmic ligand-activated transcription factor, to trigger oxidative stress, inflammation in chronic kidney disease [ 38 ]. via UPLC-based metabolomics technology, we constructed the important position of tryptophan metabolism once again and revealed novel metabolites derived from tryptophan in DG, which may provide fruitful insights into the study on DG pathogenesis.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, the metabolites of tryptophan metabolism can act as the ligands binding to specific receptors to elicited various pathologic cellular process. For example, kynurenine, serotonin and indole derivatives may bind to aryl hydrocarbon receptor (AHR), a cytoplasmic ligand-activated transcription factor, to trigger oxidative stress, inflammation in chronic kidney disease [ 38 ]. via UPLC-based metabolomics technology, we constructed the important position of tryptophan metabolism once again and revealed novel metabolites derived from tryptophan in DG, which may provide fruitful insights into the study on DG pathogenesis.…”
Section: Discussionmentioning
confidence: 99%
“…According to the latest global kidney disease health report released by the World Kidney Conference in 2021, 1 out of 10 people in the world suffers from kidney disease [25]. In recent years, more and more evidence has shown that there are disorders of intestinal ora and impaired intestinal barrier function in patients with chronic kidney disease [26][27][28][29][30]. Therefore, more and more scienti c experiments are investigated the mechanism of the intestinal-renal axis in CKD, hoping to delay its progress by regulating the intestinal ora.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, an adenine-induced rats model provides a potential platform to study the progression of CRF. In the past few decades, substantial advances have been made in understanding the underlying pathophysiology of CRF, leading to the development of novel pharmaceuticals and interventional therapies [6,7]. Tragically, efficient treatment in the clinical setting are scarce and often ineffective to either stop or reverse progression of CRF, underscoring the importance of novel therapeutics on disease intervention.…”
Section: Introductionmentioning
confidence: 99%